Tony Jourdan

Statistics

Publications

Citations

2.5K

H-Index

Active since

2007

Affiliations

National Institute on Alcohol Abuse and Alcoholism(Current)

National Institutes of Health

Université de Bourgogne

Inserm

National Institute of Diabetes and Digestive and Kidney Diseases

Tony Jourdan is an author at National Institute on Alcohol Abuse and Alcoholism specializing in pharmacology, life sciences, and cannabinoid pharmacology.

ORCID

Publications per year

2007–2023

Publications

Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes

Tony Jourdan, Grzegorz Godlewski, Adeline Bertola et al. · Nature Medicine · 2013 · 406 citations

Life Sciences, Endocrinology, Immunology +17

Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance

Joseph Tam, Jie Liu, Grzegorz Godlewski et al. · Cell Metabolism · 2012 · 348 citations · Full text

Medicine, Endocrinology, Pharmacology +12

Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides

Grzegorz Godlewski, Jie Liu, Joseph Tam et al. · Hepatology · 2013 · 168 citations

Medicine, Endocrinology, Pharmacology +17

CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice

Tony Jourdan, Louiza Djaouti, Laurent Demizieux et al. · Diabetes · 2010 · 159 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy

Tony Jourdan, Gergő Szanda, Avi Z. Rosenberg et al. · Proceedings of the National Academy of Sciences · 2014 · 136 citations · Full text

Medicine, Endocrinology, Nephrology +17

1–5 of 33